|
|
Johnson and Johnson (JNJ) |
|
|
|
| |
JNJ's Free Cash Flow Growth by Quarter and Year
Johnson And Johnson's Free Cash Flow results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Free Cash Flow Growth Y/Y▼
|
Free Cash Flow Growth Y/Y▼
|
| JNJ Free Cash Flow (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
January |
-
|
5,732.00
|
8,343.00
|
6,398.00
|
| III Quarter |
October |
-
|
8,290.00
|
8,383.00
|
7,527.00
|
| II Quarter |
July |
-
|
5,314.00
|
3,452.00
|
5,948.00
|
| I Quarter |
April |
3,979.00
|
4,074.00
|
3,358.00
|
3,543.00
|
| FY |
|
3,979.00
|
23,410.00
|
23,536.00
|
23,416.00
|
| JNJ Free Cash Flow first quarter 2022 Y/Y Growth Comment |
Johnson And Johnson reported decrease in Free Cash Flow in the first quarter 2022 by -2.33% to $ 3,979.00 millions, from the same quarter in 2021.
The decrease in the first quarter 2022 Johnson And Johnson's Free Cash Flow compares unfavorably to the Company's average Free Cash Flow growth of 0.8%.
Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Free Cash Flow growth. While Johnson And Johnson' s Free Cash Flow decline of -2.33% ranks overall at the positon no. 274 in the first quarter 2022.
|
| JNJ Free Cash Flow ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
January |
- |
-31.3 % |
30.4 % |
2.47 % |
| III Quarter |
October |
- |
-1.11 % |
11.37 % |
20.01 % |
| II Quarter |
July |
- |
53.94 % |
-41.96 % |
-2.15 % |
| I Quarter |
April |
-2.33 % |
21.32 % |
-5.22 % |
-1.75 % |
| FY |
|
- |
-0.54 % |
0.51 % |
5.47 % |
JNJ Free Cash Flow (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
January |
- |
-30.86 % |
-0.48 % |
-15 % |
| III Quarter |
October |
- |
56 % |
142.84 % |
26.55 % |
| II Quarter |
July |
- |
30.44 % |
2.8 % |
67.88 % |
| I Quarter |
April |
-30.58 % |
-51.17 % |
-47.51 % |
-43.26 % |
| FY (Year on Year) |
|
- |
-0.54 % |
0.51 % |
5.47 % |
| Free Cash Flow Y/Y Growth Statistics |
| High |
Average |
Low |
| 10.72 % |
0.8 % |
-18.46 % |
| (March 31, 2014) |
|
(Sep. 30, 2011) |
|
|
| Free Cash Flow Y/Y Growth Statistics |
| High |
Average |
Low |
| 10.72 % |
0.8 % |
-18.46 % |
| (March 31, 2014) |
|
(Sep. 30, 2011) |
|
| Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Johnson And Johnson's Q/Q Free Cash Flow Growth
| Free Cash Flow Q/Q Growth Statistics |
| High |
Average |
Low |
| 471.43 % |
22.26 % |
-100 % |
| (Jan 03 2016) |
|
|
| JNJ's I. Quarter Q/Q Free Cash Flow Comment |
In the I. Quarter 2022 Johnson And Johnson disclosed fall in Free Cash Flow from the previous quarter by -30.58% to $ 3,979.00 millions, from $ 5,732.00 millions declared in the previous reporting period.
It's not important problem, as Free Cash Flow always tend to dip in this quarter.
Within Major Pharmaceutical Preparations industry 25 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Johnson And Johnson's Free Cash Flow growth quarter on quarter, overall rank is 1018. |
|
|
|
| Free Cash Flow Q/Q Growth Statistics |
| High |
Average |
Low |
| 471.43 % |
22.26 % |
-100 % |
| (Jan 03 2016) |
|
|
| JNJ's I. Quarter Q/Q Free Cash Flow Comment |
In the I. Quarter 2022 Johnson And Johnson disclosed fall in Free Cash Flow from the previous quarter by -30.58% to $ 3,979.00 millions, from $ 5,732.00 millions released a quarter before.
But that's not huge concern, as Johnson And Johnson's Free Cash Flow frequently seem to dip in this quarter.
Within Major Pharmaceutical Preparations industry 25 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Johnson And Johnson's Free Cash Flow growth quarter on quarter, overall rank is 1018. |
|
Johnson And Johnson's 12 Months Free Cash Flow Growth Year on Year
Free Cash Flow TTM Growth |
12 Months Ending
(Apr 03 2022) |
12 Months Ending
(Jan 02 2022) |
12 Months Ending
(Oct 03 2021) |
12 Months Ending
(Jul 04 2021) |
12 Months Ending
(Apr 04 2021) |
| Cumulative Free Cash Flow 12 Months Ending |
$ 26,897.00 |
$ 27,062.00 |
$ 29,581.00 |
$ 29,664.00 |
$ 27,651.00 |
| Y / Y Free Cash Flow Growth (TTM) |
-2.73 % |
0.67 % |
18.92 % |
23.46 % |
3.57 % |
| Year on Year Free Cash Flow Growth Overall
Ranking |
# 291 |
# 1365 |
# 1074 |
# 238 |
# 1315 |
| Seqeuential Free Cash Flow Change (TTM) |
-0.61 % |
-8.52 % |
-0.28 % |
7.28 % |
2.86 % |
| Seq. Free Cash Flow Growth (TTM) Overall
Ranking |
# 274 |
# 503 |
# 1507 |
# 551 |
# 1427 |
| Cumulative Free Cash Flow growth
Comment |
For the 12 months ended Apr 03 2022 Johnson And Johnson reported a decrease in Free Cash Flow by -2.73% year on year, to $26,897 millions, compare to the 0.67% growth at Jan 02 2022.
Among companies within the Healthcare sector 20 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 291, from total ranking in previous quarter at 1365. |
| Free Cash Flow TTM Q/Q Growth Statistics |
| High |
Average |
Low |
10.72 % |
0.8 % |
-18.46 % |
|
|
|
|
|
| Free Cash Flow TTM Y/Y Growth Statistics |
| High |
Average |
Low |
24.41 % |
4.68 % |
-29.74 % |
|
|
|
| Free Cash Flow TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 4 |
| Sector |
# 16 |
| S&P 500 |
# 274 |
|
| Cumulative Free Cash Flow growth
Comment |
For the 12 months ended Apr 03 2022 Johnson And Johnson reported a decrease in Free Cash Flow by -2.73% year on year, to $26,897 millions, compare to the 0.67% growth at Jan 02 2022.
Among companies within the Healthcare sector 20 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 291, from total ranking in previous quarter at 1365. |
| Free Cash Flow TTM Q/Q Growth Statistics |
| High |
Average |
Low |
10.72 % |
0.8 % |
-18.46 % |
|
|
|
| Free Cash Flow TTM Y/Y Growth Statistics |
| High |
Average |
Low |
24.41 % |
4.68 % |
-29.74 % |
|
|
|
| Free Cash Flow TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 4 |
| Sector |
# 16 |
| S&P 500 |
# 274 |
|
